Gene expression analysis of electrical therapies on glioblastoma cell lines
Ontology highlight
ABSTRACT: The scarcity of effective treatment options for high grade brain tumours has led to a wide ranging search for alternative means of therapy for these difficult to treat tumours. Electrical field therapy is one such area that has been considered. The OptuneTM system is an FDA approved novel anti-mitotic device that delivers continuous alternating electric fields to the patient for the treatment of primary and recurrent Glioblastoma multiforme (GBM) (tumor treating fields - TTFields). Alternative electric fields delivery systems are also being investigated for the treatment of various cancers.To further explore alternative potential mechanisms of electric fields as a whole, we ran Optune, DBS electric fields treated and control untreated KNS42, U87 and GIN-31 (primary) cell lines on Clariom S Human Assays to produce genome-wide expression data.
ORGANISM(S): Homo sapiens
SUBMITTER: Stuart Smith
PROVIDER: E-MTAB-9043 | biostudies-arrayexpress |
REPOSITORIES: biostudies-arrayexpress
ACCESS DATA